Ultimate Strength Properties of Control and Explanted Silastic O and Silastic I Silicone Gel-filled Breast Implant Shells
Background
The effect of in vivo implantation on breast implants is important to both physicians and patients, but little information about the in vivo aging process of silicone gel-filled breast implants has appeared in the literature. The effects of the in vivo aging process could affect the durability of breast implants.
Objective
The purpose of this study was to investigate changes in the mechanical and chemical properties of breast implant shells as a function of implantation time.
Methods
The ultimate mechanical properties of the shells from single-lumen silicone gel-filled Silastic O and Silastic I explants with in vivo duration times ranging from 6 to 28 years were measured and compared with the corresponding properties of unimplanted control single-lumen silicone gel-filled implants. Ultimate tensile strength, elongation-to-failure, and tear resistance were measured for both explant and control shells through use of identical testing protocols. In addition, the tensile strength and elongation-to-failure of shells extracted with hexane to remove non–cross-linked silicones were measured for both explants and control implants. The ultimate strength data were plotted as a function of implantation time, along with data from other research institutions.
Results
Statistical analysis of the data indicated that the ultimate mechanical properties of tensile strength, elongation-to-failure, and tear resistance are not functions of implantation time for up to 28 years of implantation.
Conclusions
The results of this study show that there is no significant degradation of the mechanical properties of the elastomeric shell as a function of time.
Related Projects
- Published on Jun 10, 2024A subset of females with breast implants have reported a myriad of nonspecific systemic symptoms collectively termed systemic symptoms associated with breast implants (SSBI).
- Published on Jul 11, 2023Aesthetic surgery fellowship applications were consolidated under the San Francisco Match in 2018. The impact of these changes on aesthetic program and applicant numbers had not yet been investigated.
- Published on Apr 12, 2023Breast Implant Illness (BII) describes a variety of symptoms reported by patients with breast implants. Biospecimens data revealed minimal statistical differences between BII and non-BII cohorts. Baseline analysis of PROMIS data demonstrated significant...